Option chain shows key data for Creative Medical Tech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Creative Medical Tech.

Creative Medical Tech (NASDAQ:CELZ) Stock, Option Chain

Creative Medical Tech

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AEYE

AISP

ANTE

ARHS

AVGR

BENF

BREA

CDMO

CELZ

CERO

CIEN

CMPO

CRBP

DAVE

EHAB

ETWO

GROM

HDSN

HNST

MNMD

NEXI

NWGL

OCEA

OSPN

STVN

SWIN

TPVG

VKTX

VSCO

YEXT

YGMZ

Shares of  HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Diabetes

Biotech

Health Care

General

FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose tolerance to prevent Type 1 diabetes.

Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?

Creative Medical Technology Holdings (NASDAQ: CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem™ For Addressing Chronic Lower Back Pain

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Technology Holdings Inc

Press Releases

Creative Medical Technology Holdings Provides Corporate Update

Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program

Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain

Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™

Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Alzamend Neuro

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Azitra

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

GT Biopharma

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Mustang Bio

Moleculin Biotech

Oragenics

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Portage Biotech

Plus Therapeutics

Sunshine Biopharma

SILO Pharma

Soligenix

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Xenetic Biosciences

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Comments

Creative Medical Tech

Creative Medical Tech (CELZ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga